# A Study of Ascending Multiple Doses of Oral Surotomycin in Healthy Participants (MK-4261-009)

> **NCT02835118** · PHASE1 · COMPLETED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 30 (actual)

## Conditions studied

- Clostridium Difficile Associated Diarrhea (CDAD)

## Interventions

- **DRUG:** Surotomycin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02835118
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-07
- **Primary completion:** 2009-10
- **Final completion:** 2009-10
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2016-07-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02835118

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02835118, "A Study of Ascending Multiple Doses of Oral Surotomycin in Healthy Participants (MK-4261-009)". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02835118. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*